Cite

HARVARD Citation

    Orkin, C. et al. (2020). Once-daily Doravirine in Human Immunodeficiency Virus Type 1–Infected, Antiretroviral-naive Adults: An Integrated Efficacy Analysis. Clinical infectious diseases. pp. 1344-1352. [Online]. 
  
Back to record